Adastra Holdings Ltd.: Adastra Labs Clarifies and Retracts C

Adastra Holdings Ltd.: Adastra Labs Clarifies and Retracts Certain Disclosure Related to its Receipt of Health Canada Approval for the Amendment to Include Cocaine Under its Controlled Substances Licence

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESLANGLEY, BC / ACCESSWIRE / March 3, 2023 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the

Related Keywords

United States , Canada , United Kingdom , Langley , Northumberland , British , Canadian , Dennis Riedl , Alyssa Barry , Michael Forbes , Adastra Holdings Ltd View , Health Canada , Adastra Labs Inc , Adastra Holdings Ltd , Adastra Holdings , Controlled Substances Licence , Adastra Labs , Controlled Drugs , Substances Act , Phyto Extractions , British Columbia , Corporate Secretary , Vadastra , Oldings , Labs , Clarifies , Retracts , Certain , Disclosure , Elated , Receipt , Health , Approval , Amendment , Nclude , Cocaine , Under , Ontrolled , Substances , Licence ,